COVID-19—A Trigger Factor for Severe Immune-Mediated Thrombocytopenia in Active Rheumatoid Arthritis
Thrombocytopenia is defined as a platelet count below 150,000/mm<sup>3</sup> for adults. There is still controversy about whether individuals with platelet counts of 100,000/mm<sup>3</sup> to 150,000/mm<sup>3</sup> should be classified as having genuine thrombocyt...
Main Authors: | Anca Bobircă, Florin Bobircă, Ioan Ancuța, Anca Florescu, Mihai Bojincă, Alice Muscă, Dan Nicolae Florescu, Lucian Mihai Florescu, Romina Marina Sima, Alesandra Florescu, Anca Emanuela Mușetescu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/12/1/77 |
Similar Items
-
Characteristics of Anemia in Rheumatoid Arthritis
by: Anca BOBIRCA, et al.
Published: (2022-09-01) -
Comparison between Young and Elderly Onset of Rheumatoid Arthritis in a Romanian Cohort
by: Anca BOBIRCA, et al.
Published: (2022-03-01) -
Novel Biomarkers, Diagnostic and Therapeutic Approach in Rheumatoid Arthritis Interstitial Lung Disease—A Narrative Review
by: Alesandra Florescu, et al.
Published: (2022-06-01) -
Rheumatic Immune-Related Adverse Events—A Consequence of Immune Checkpoint Inhibitor Therapy
by: Anca Bobircă, et al.
Published: (2021-06-01) -
Anti-MDA5 Amyopathic Dermatomyositis—A Diagnostic and Therapeutic Challenge
by: Anca Bobirca, et al.
Published: (2022-07-01)